Agreement Between High-Risk Human Papillomavirus Testing in Paired Self-Collected and Clinician-Collected Samples from Cervical Cancer Screening in Spain
<b>Background</b>: Implementing self-sampling (SS) in cervical cancer screening requires comparable results to clinician-collected samples (CCS). Agreement measures are essential for evaluating HPV test performance. Previous studies on non-paired samples have reported higher viral cycle threshold (Ct) values in SS compared to CCS, affecting sensitivity for detecting cervical intraepithelial neoplasia grade 2 or worse (CIN2+). <b>Objectives:</b> We aimed to evaluate the agreement of high-risk (hr)HPV testing results between SS and CCS using paired samples and to explore differences in Ct values. <b>Methods</b>: Women aged 30 to 65 years attending cervical cancer screening in two regions of Spain were invited to participated in this study. For each woman there was: CCS collected during the screening visit using liquid-based cytology and cytobrush, and a SS using a brush at home one month later. A PCR-based assay was used for hrHPV detection. Agreement in hrHPV results among both samples, Ct value differences, and their association with screening outcomes were analyzed. <b>Results</b>: This study included 981 women with paired samples. SS had a higher hrHPV prevalence than CCS (overall ratio of 1.3). Positive agreement for all hrHPV genotypes, HPV16, HPV18, and other hrHPV types were 85%, 91.3%, 66.7%, and 83.3%, respectively. Negative agreement was >95% for all results. Median Ct values was slightly higher in SS than in CSS (32.9 vs. 30.6, <i>p</i> = 0.02). Seven CIN2+ cases HPV positive were detected by both methods. One CIN3 case was missed by SS. <b>Conclusions</b>: This study showed a good agreement between SS and CCS for hrHPV testing in a routine screening in Spain. Despite the slightly higher Ct values for SS, no significant impact on sensitivity could be determined due to the low incidence of CIN2+ cases. Further research on larger paired samples is needed to assess the implications of Ct values on test sensitivity.
Authors
- Sílvia de Sanjosé (ORCID: https://orcid.org/0000-0002-5909-676X)
- Amèlia Acera (ORCID: https://orcid.org/0000-0002-2010-7310)
- Esther Roura (ORCID: https://orcid.org/0000-0003-2195-9125)
- Laia Bruni (ORCID: https://orcid.org/0000-0003-3943-0326)
- Miguel Andújar (ORCID: https://orcid.org/0000-0002-4858-6915)
- Raquel Ibáñez (ORCID: https://orcid.org/0000-0003-3324-8312)
- Francisca Morey (ORCID: https://orcid.org/0000-0001-5329-9649)
- Miguel Ángel Pavón (ORCID: https://orcid.org/0000-0003-3677-5329)
Institutions
- Hospital Universitario Insular de Gran Canaria (ES)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Institut Català d'Oncologia (ES)
- Barcelona Institute for Global Health (ES)
- Institut Català de la Salut (ES)
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (ES)
Publication Details
- Journal
- Cancers
- Published
- 2024-12-29
- DOI
- https://doi.org/10.3390/cancers17010063
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Instituto de Salud Carlos III